Study Reveals 1 in 4 Indian Diabetics Has Liver Fibrosis, A Major Complication
A groundbreaking 2026 multicentre study, known as the DiaFib-Liver Study, has uncovered a critical and often-overlooked link between Type 2 Diabetes and liver damage in India. The research, involving over 9,000 Indian adults, highlights that liver fibrosis—scarring of the liver—is alarmingly common among diabetics, challenging traditional views of diabetes complications.
Key Findings: Liver Fibrosis as a "Fourth Major Complication"
The study found that one in four adults with Type 2 Diabetes in India has clinically significant liver fibrosis, while one in twenty already shows probable cirrhosis based on elastography thresholds. This establishes advanced liver disease as a "fourth major complication" of diabetes, alongside microvascular issues like retinopathy, nephropathy, and neuropathy. Researchers emphasize that fibrosis, not just steatosis (fat accumulation), should be the focus of systematic assessment in diabetes care.
Understanding the Connection: Diabetes and Liver Health
Dr. Kapil Sharma, Group Director of Gastroenterology at Yatharth Super Speciality Hospital, Faridabad, explains the link. Insulin resistance in diabetes leads to excess fat and glucose storage, causing fat to accumulate in the liver. This condition, now termed Metabolic dysfunction-associated steatotic liver disease (MASLD), affects up to 70% of diabetics. Over time, it can trigger inflammation and fibrosis, where healthy liver tissue is replaced by scar tissue through pathways like chronic inflammatory responses and abnormal lipid metabolism.
Risk Factors and Preventive Measures
Dr. Sharma identifies key risk factors for liver disease in diabetics, including obesity, poor glucose control, hypertriglyceridemia, metabolic syndrome, increased waist circumference, and elevated hepatic enzymes. Even with normal liver tests, diabetics face a higher risk of advanced fibrosis due to silent progression.
To prevent liver damage, he recommends:
- Controlling weight through a balanced diet and regular exercise.
- Reducing consumption of refined carbohydrates and alcohol.
- Maintaining low blood sugar levels to decrease liver damage risk.
- Undergoing regular screening tests, such as liver enzyme testing and FibroScan, for early detection.
- Managing cholesterol and blood pressure to prevent cirrhosis or fibrosis.
Why Focus on Fibrosis Over Steatosis?
Dr. Sharma clarifies the distinction: steatosis involves reversible fat accumulation with few immediate complications if detected early. In contrast, fibrosis indicates scar tissue formation from ongoing damage and inflammation, signaling disease progression toward severe outcomes like cirrhosis, liver failure, and increased mortality. Thus, screening for fibrosis is crucial as it better marks disease severity and long-term complications.
The study underscores the need for heightened awareness and proactive management in diabetes care to address this hidden connection, potentially improving health outcomes for millions in India.
